Experimental and clinical results with Avemar (a dried extract from fermented weath germ) in animal cancer models and in cancer patients

Nichelatti M, Hidvégi M (2002): Experimental and clinical results with Avemar (a dried extract from fermented weath germ) in animal cancer models and in cancer patients. Nőgyógyászati Onkológia. 7:40-1.
Abstract

In the late 1990's, reports were published about a biotech process by which a fermented wheat germ extract could be produced. The product, called Avemar, available as a water soluble granulate for oral consumption, has gained much attention from cancer researchers of several countries, like Israel, Hungary, the United States, England and Russia. Studies show biological activity of Avemar that may be useful for the treatment of neoplastic diseases, effects which can be well used in the treatment of certain immune disturbances and improvement in patient quality of life which can be independent from the previous ones. ANIMAL EXPERIMENTS: Avemar treatment resulted in a statistically significant decreases in metastases compared with controls, 71% with 3LL-HH tumor (Lewis lung carcinoma), 50% decrease with HCR-25 human colon carcinoma and 85% with B16 melanoma. When used in combination with chemotherapy, Avemar did not reduce cytotoxic effect on primary tumors, but dramatically enhanced antimetastatic effect.

Search publications